Insider trades › Target · Target company page
Target insider trading
Transactions in TGT stock reported by Target executives, directors and large holders on SEC Form 4 over the last 120 days. Last update 2026-10-03.
$11.9Mopen-market sales (73,426 shares, 4 insiders)
$0open-market purchases (0 shares, 0 insiders)
8Form 4 filings
Insiders
Brian C Cornell Executive Officer, Director Sold $8.2M Melissa K Kremer Executive Officer Sold $2.6M Lisa R Roath Executive Officer Sold $966K Matthew A Liegel Chief Accounting Officer Sold $151K Mark A. Weinstein Executive Officer 2 other transactions James Lee Executive Officer 1 other transaction Joseph Michael DePinto Director 1 other transaction Grant B McGee Executive Officer 2 other transactions
All transactions
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Mark A. Weinstein Executive Officer | Grant or award | 2,142 | — | — | Form 4 ↗ |
| Sep 30, 2026 | Mark A. Weinstein Executive Officer | Grant or award | 23,787 | — | — | Form 4 ↗ |
| Sep 30, 2026 | James Lee Executive Officer | Shares withheld for tax | 7,636 | $157.94 | — | Form 4 ↗ |
| Aug 25, 2026 | Brian C Cornell Executive Officer, Director | Open-market sale indirect | 50,000 | $163.56 | $8.2M | Form 4 ↗ |
| Aug 24, 2026 | Melissa K Kremer Executive Officer | Open-market sale | 15,500 | $169.96 | $2.6M | Form 4 ↗ |
| Aug 21, 2026 | Matthew A Liegel Chief Accounting Officer | Open-market sale | 926 | $163.51 | $151K | Form 4 ↗ |
| Aug 3, 2026 | Joseph Michael DePinto Director | Grant or award | 1,007 | — | — | Form 4 ↗ |
| Jun 30, 2026 | Grant B McGee Executive Officer | Grant or award | 4,127 | — | — | Form 4 ↗ |
| Jun 30, 2026 | Grant B McGee Executive Officer | Grant or award | 15,282 | — | — | Form 4 ↗ |
| Jun 29, 2026 | Lisa R Roath Executive Officer | Open-market sale | 7,000 | $138.07 | $966K | Form 4 ↗ |
Source: SEC EDGAR, Target Form 4 filings. Values are shares × reported price for open-market trades. Insider trades are reported facts, not recommendations. Not investment advice. See the tracker for how to read the codes.